Stay updated with breaking news from Tim Walbert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Third-Quarter 2022 Results: -- Net Sales of $925.4 Million -- -- GAAP Net Income of $135.8 Million; Adjusted EBITDA of $335.3 Million, Which Includes $19.0 Million of Acquired IPR&D and Milestones
--Organization Will Utilize GPS and Web Services to Build a Patient-Driven Platform for the Epidermolysis Bullosa (EB) Community and Accelerate a Cure -- Horizon Therapeutics plc (Nasdaq: HZNP), in
Novel Program Supports Student Education and Future Careers in Patient Advocacy Horizon Therapeutics plc (Nasdaq: HZNP) today announced it has made a founding, five-year gift to establish the University
Support from Horizon Therapeutics will enable the Patient Advocacy Initiative to provide comprehensive programming that advances training, outreach and ...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that its Board of Directors authorized the repurchase of up to $500 million of the Company's ordinary shares. "This share repurchase program